Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults.

Black S, Shinefield H, Baxter R, Austrian R, Elvin L, Hansen J, Lewis E, Fireman B.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-79-80.

PMID:
16823937
2.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.

PMID:
15194827
3.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
4.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

5.
6.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
7.

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.

Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J; Massachusetts Department of Public Health Epidemiologists.

Pediatr Infect Dis J. 2005 Jan;24(1):17-23.

PMID:
15665705
8.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
9.

[Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].

de Arístegui Fernández J, Corretger Rauet JM, García Martín F, Hernández-Sampelayo T, Moraga Llop FA, Rodrigo Gonzalo De Liria C, Ruiz Contreras J; Comité Asesor deVacunas de la Asociación Española de Pediatría.

An Esp Pediatr. 2002 Jan;56(1):79-90. Review. Spanish.

PMID:
11792258
10.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087. Epub 2008 Apr 18.

PMID:
18456376
11.

Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.

Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M.

Eur J Health Econ. 2008 Feb;9(1):7-15. Epub 2007 Mar 2.

PMID:
17333089
12.

Prevenar vaccination: review of the global data, 2006.

Center KJ.

Vaccine. 2007 Apr 20;25(16):3085-9. Epub 2007 Jan 18. Review.

PMID:
17287048
13.

Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.

Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM.

Pediatrics. 2008 Mar;121(3):562-9. doi: 10.1542/peds.2007-0018.

PMID:
18310206
14.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.

Clin Infect Dis. 2008 Oct 15;47(8):989-96. doi: 10.1086/591966.

PMID:
18781875
15.

Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.

Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL.

Clin Infect Dis. 2006 Apr 1;42(7):907-14. Epub 2006 Feb 27.

PMID:
16511752
16.

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine.

Aristegui J, Bernaola E, Pocheville I, García C, Arranz L, Durán G, Pérez L, Bastida M, Canduela C, Herranz Aguirre M, Garrote E, Fletcher MA, Pérez C.

Eur J Clin Microbiol Infect Dis. 2007 May;26(5):303-10.

PMID:
17457623
17.

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F.

Pediatr Infect Dis J. 2001 Dec;20(12):1105-7.

PMID:
11740313
18.

A conjugate vaccine for the prevention of pediatric pneumococcal disease.

Murray D, Jackson C.

Mil Med. 2002 Aug;167(8):671-7. Review.

PMID:
12188240
19.

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.

Black SB, Shinefield HR, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J.

Pediatr Infect Dis J. 2002 Sep;21(9):810-5.

PMID:
12352800
20.

Supplemental Content

Support Center